iShares Neuroscience and HeaIBRNETF
13F holders, Q1 2025 (March 31)4holders +2
2new positions
0sold out
$22.37avg. 13F price*
At the end of Q1 2025, 4 institutions reported holding iShares Neuroscience and Hea (IBRN) in their 13F filings, up 2 from Q4 2024. 2 opened new positions and 0 sold out. The largest holders were BlackRock, Inc. ($2.3M), Flow Traders U.S. LLC ($260K) and Principal Securities, Inc. ($19K).
- Company
- iShares Neuroscience and Hea
- CUSIP
- 46436E353
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $264K |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 11,778 shares bought, net +11,778 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| BlackRock, Inc. | 0.00% | No change | 103,000 | $2.3M |
| Flow Traders U.S. LLC | 0.01% | New | 11,615 | $260K |
| Principal Securities, Inc. | 0.00% | No change | 732 | $19K |
| Cwm, LLC | 0.00% | New | 163 | $4K |
"% of holder's portfolio" is IBRN's weight in each manager's 13F, not the share of iShares Neuroscience and Hea the manager owns.